Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
AIDS and Behavior
Erschienen in: AIDS and Behavior 8/2019

17.10.2018 | Original Paper

Antiretroviral Adherence Trajectories Among Black Americans Living with HIV

verfasst von: Erik D. Storholm, Laura M. Bogart, Matt G. Mutchler, David J. Klein, Bonnie Ghosh-Dastidar, Bryce McDavitt, Glenn J. Wagner

Erschienen in: AIDS and Behavior | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Abstract

Black people living with HIV (BPLWH) are less likely to adhere to antiretroviral treatment than are members of other racial/ethnic groups. Data were combined from two studies of BPLWH (n = 239) to estimate adherence trajectories using a semiparametric, group-based modeling strategy over three time-points (spanning 6 months). Analyses identified three groups of individuals (high-stable, moderately low-stable, low-decreasing). Multinomial logistic regressions were used to predict trajectory membership with multiple levels of socio-ecological factors (structural, institutional/health system, community, interpersonal/network, individual). Older age was associated with being in the high-stable group, whereas substance use, lower perceived treatment effectiveness, and lower quality healthcare ratings were related to being in the moderately low-stable group. In sum, multiple socio-ecological factors contribute to adherence among BPLWH and thus could be targeted in future intervention efforts.
Literatur
1.
Crepaz N. Racial and ethnic disparities in sustained viral suppression and transmission risk potential among persons receiving HIV care—United States, 2014. MMWR. 2018;67:113.PubMed
2.
Cunningham W. HIV racial disparities: comment on “The influence of sex, race/ethnicity, and educational attainment on human immunodeficiency virus death rates among adults, 1993–2007”. Arch Intern Med. 2012;172(20):1599–600.CrossRefPubMed
3.
Simoni JM, Huh D, Wilson IB, Shen J, Goggin K, Reynolds NR, et al. Racial/ethnic disparities in ART adherence in the United States: findings from the MACH14 study. J Acquir Immune Defic Syndr. 2012;60(5):466.CrossRefPubMedPubMedCentral
4.
5.
6.
Attia S, Egger M, Müller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS. 2009;23(11):1397–404.CrossRefPubMed
7.
Castilla J, Del Romero J, Hernando V, Marincovich B, García S, Rodríguez C. Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. J Acquir Immune Defic Syndr. 2005;40(1):96–101.CrossRefPubMed
8.
Del Romero J, Castilla J, Hernando V, Rodríguez C, García S. Combined antiretroviral treatment and heterosexual transmission of HIV-1: cross sectional and prospective cohort study. BMJ. 2010;340:c2205.CrossRefPubMedPubMedCentral
9.
Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, Cohen CR, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet HIV. 2010;375(9731):2092–8.CrossRef
10.
Trickey A, May MT, Vehreschild JJ, Obel N, Gill MJ, Crane HM, et al. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV. 2017;4(8):e349–56.CrossRef
11.
Kaufman MR, Cornish F, Zimmerman RS, Johnson BT. Health behavior change models for HIV prevention and AIDS care: practical recommendations for a multi-level approach. J Acquir Immune Defic Syndr. 2014;66(Suppl 3):S250.CrossRefPubMed
12.
Johnson BT, Redding CA, DiClemente RJ, Mustanski BS, Dodge B, Sheeran P, et al. A network-individual-resource model for HIV prevention. AIDS Behav. 2010;14(2):204–21.CrossRefPubMedPubMedCentral
13.
Crosby RA, Salazar LF, DiClemente RJ. Ecological approaches in the new public health. Health behavior theory for public health: principles, foundations, and applications. Massachusetts: Jones & Bartlett Learning; 2011. p. 231–51.
14.
Hermanstyne K. Links between substance use behavior and sexual risk behavior patterns within social networks of high-risk Black MSM in 6 US cities. Primary Paper: No Ancillary Study: No Date soundbite disseminated to 061 Pubs Team: 22 April 2014.
15.
Schneider JA, Cornwell B, Ostrow D, Michaels S, Schumm P, Laumann EO, et al. Network mixing and network influences most linked to HIV infection and risk behavior in the HIV epidemic among Black men who have sex with men. Am J Public Health. 2013;103(1):e28–36.CrossRefPubMedPubMedCentral
16.
Galea S, Nandi A, Vlahov D. The social epidemiology of substance use. Epidemiol Rev. 2004;26(1):36–52.CrossRefPubMed
17.
Rumptz MH, Tobias C, Rajabiun S, Bradford J, Cabral H, Young R, et al. Factors associated with engaging socially marginalized HIV-positive persons in primary care. AIDS Patient Care STDs. 2007;21(S1):S-30-S-9.CrossRef
18.
Shapiro MF, Morton SC, McCaffrey DF, Senterfitt JW, Fleishman JA, Perlman JF, et al. Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study. JAMA. 1999;281(24):2305–15.CrossRefPubMed
19.
Kingdon MJ, Storholm ED, Halkitis PN, Jones DC, Moeller RW, Siconolfi D, et al. Targeting HIV prevention messaging to a new generation of gay, bisexual, and other young men who have sex with men. J Health Commun. 2013;18(3):325–42.CrossRefPubMed
20.
Naar-King S, Bradford J, Coleman S, Green-Jones M, Cabral H, Tobias C. Retention in care of persons newly diagnosed with HIV: outcomes of the outreach initiative. AIDS Patient Care STDS. 2007;12(suppl 1):S40–8.CrossRef
21.
Tobias C, Cunningham WE, Cunningham CO, Pounds MB. Making the connection: the importance of engagement and retention in HIV medical care. AIDS Patient Care STDs. 2007;21(suppl 1):S3–8.CrossRefPubMed
22.
Cunningham WE, Andersen RM, Katz MH, Stein MD, Turner BJ, Crystal S, et al. The impact of competing subsistence needs and barrier on access to medical care for persons with human immunodeficiency virus receiving care in the United States. Med Care. 1999;37(12):1270–81.CrossRefPubMed
23.
Landrine H, Klonoff EA. Cultural diversity and health psychology. In: Baum A, Singer J, Revenson T, editors. Handbook of health psychology. Mahway: Erlbaum; 2001. p. 855–95.
24.
Brandon DT, Isaac LA, LaVeist TA. The legacy of Tuskegee and trust in medical care: is Tuskegee responsible for race differences in mistrust of medical care? J Natl Med Assoc. 2005;97(7):951–6.PubMedPubMedCentral
25.
Armstrong K, McMurphy S, Dean LT, Micco E, Putt M, Halbert CH, et al. Differences in the patterns of health care system distrust between Blacks and Whites. J Gen Intern Med. 2008;23(6):827–33.CrossRefPubMedPubMedCentral
26.
Armstrong K, Ravenell KL, McMurphy S, Putt M. Racial/ethnic differences in physician distrust in the United States. Am J Public Health. 2007;97(7):1283–9.CrossRefPubMedPubMedCentral
27.
Bogart LM, Bird ST, Walt LC, Delahanty DL, Figler JL. Association of stereotypes about physicians to health care satisfaction, help-seeking behavior, and adherence to treatment. Soc Sci Med. 2004;58(6):1049–58.CrossRefPubMed
28.
Bogart LM, Wagner G, Galvan FH, Banks D. Conspiracy beliefs about HIV are related to antiretroviral treatment nonadherence among African American men with HIV. J Acquir Immune Defic Syndr. 2010;53(5):648–55.PubMedPubMedCentral
29.
Bogart LM, Wagner GJ, Green HD, Mutchler MG, Klein DJ, McDavitt B, et al. Medical mistrust among social network members may contribute to antiretroviral treatment nonadherence in African Americans living with HIV. Soc Sci Med. 2016;164:133–40.CrossRefPubMedPubMedCentral
30.
Bogart LM, Wagner GJ, Green HD, Mutchler MG, Klein DJ, McDavitt B. Social network characteristics moderate the association between stigmatizing attributions about HIV and non-adherence among Black Americans living with HIV: a longitudinal assessment. Ann Behav Med. 2015;49(6):865–72.CrossRefPubMedPubMedCentral
31.
Dale SK, Bogart LM, Wagner GJ, Galvan FH, Klein DJ. Medical mistrust is related to lower longitudinal medication adherence among African-American males with HIV. J Health Psychol. 2016;21:1311–21.CrossRefPubMed
32.
Chen FM, Fryer GEJ, Phillips RLJ, Wilson E, Pathman DE. Patients’ beliefs about racism, preferences for physician race, and satisfaction with care. Ann Fam Med. 2005;3(2):138–43.CrossRefPubMedPubMedCentral
33.
Hausmann LR, Jeong K, Bost JE, Ibrahim SA. Perceived discrimination in health care and health status in a racially diverse sample. Med Care. 2008;46(9):905–14.CrossRefPubMedPubMedCentral
34.
LaVeist TA, Nickerson KJ, Bowie JV. Attitudes about racism, medical mistrust, and satisfaction with care among African American and white cardiac patients. Med Care Res Rev. 2000;57(suppl 1):146–61.CrossRefPubMed
35.
Lillie-Blanton M, Brodie M, Rowland D, Altman D, McIntosh M. Race, ethnicity, and the health care system: public perceptions and experiences. Med Care Res Rev. 2000;57(suppl 1):218–35.CrossRefPubMed
36.
Schrimshaw EW, Siegel K, Lekas HM. Changes in attitudes toward antiviral medication: a comparison of women living with HIV/AIDS in the pre-HAART and HAART eras. AIDS Behav. 2005;9(3):267–79.CrossRefPubMed
37.
Siegel K, Karus D, Schrimshaw EW. Racial differences in attitudes toward protease inhibitors among older HIV-infected men. AIDS Care. 2000;12(4):423–34.CrossRefPubMed
38.
O’Leary A, Fisher HH, Purcell DW, Spikes PS, Gomez CA. Correlates of risk patterns and race/ethnicity among HIV-positive men who have sex with men. AIDS Behav. 2007;11(5):706–15.CrossRefPubMed
39.
Foster PP, Gaskin SW. Older African Americans’ management of HIV/AIDS stigma. AIDS Care. 2009;21(10):1306–12.CrossRefPubMed
40.
Jerome RC, Halkitis PN. Stigmatization, stress, and the search for belonging in Black men who have sex with men who use methamphetamine. J Black Psychol. 2009;35(3):343–65.CrossRef
41.
Graham LF, Braithwaite K, Spikes P, Stephens CF, Edu UF. Exploring the mental health of Black men who have sex with men. Community Ment Health J. 2009;45(4):272–84.CrossRefPubMed
42.
Malebranche DJ, Fields EL, Bryant LO, Harper SR. Masculine socialization and sexual risk behaviors among Black men who have sex with men. Men Masculinities. 2009;12(1):90–112.CrossRef
43.
44.
Bogart LM, Wagner GJ, Galvan FH, Klein DJ. Longitudinal relationships between antiretroviral treatment adherence and discrimination due to HIV-serostatus, race, and sexual orientation among African-American men with HIV. Ann Behav Med. 2010;40(2):184–90.CrossRefPubMedPubMedCentral
45.
Sayles JN, Wong MD, Cunningham WE. The inability to take medications openly at home: does it help explain gender disparities in HAART use? J Women’s Health. 2006;15(2):173–81.CrossRef
46.
Galvan FH, Bogart LM, Klein DJ, Wagner GJ, Chen YT. Medical mistrust as a key mediator in the association between perceived discrimination and adherence to antiretroviral therapy among HIV-positive Latino men. J Behav Med. 2017;40(5):784–93.CrossRefPubMedPubMedCentral
47.
Katz IT, Ryu AE, Onuegbu AG, Psaros C, Weiser SD, Bangsberg DR, et al. Impact of HIV-related stigma on treatment adherence: Systematic review and meta-synthesis. J Int AIDS Soc. 2013;16(3S2):18640.CrossRefPubMedPubMedCentral
48.
Simoni JM, Frick PA, Huang B. A longitudinal evaluation of a social support model of medication adherence among HIV-positive men and women on antiretroviral therapy. Health Psychol. 2006;25(1):74.CrossRefPubMedPubMedCentral
49.
Blashill AJ, Bedoya CA, Mayer KH, O’Cleirigh C, Pinkston MM, Remmert JE, et al. Psychosocial syndemics are additively associated with worse ART adherence in HIV-infected individuals. AIDS Behav. 2015;19(6):981–6.CrossRefPubMedPubMedCentral
50.
Kalichman SC, Grebler T. Stress and poverty predictors of treatment adherence among people with low-literacy living with HIV/AIDS. Psychosom Med. 2010;72(8):810.CrossRefPubMedPubMedCentral
51.
Mugavero MJ, Raper JL, Reif S, Whetten K, Leserman J, Thielman NM, et al. Overload: the impact of incident stressful events on antiretroviral medication adherence and virologic failure in a longitudinal, multi-site HIV cohort study. Psychosom Med. 2009;71(9):920.CrossRefPubMedPubMedCentral
52.
Wagner GJ, Bogart LM, Galvan FH, Banks D, Klein DJ. Discrimination as a key mediator of the relationship between posttraumatic stress and HIV treatment adherence among African American men. J Behav Med. 2012;35(1):8–18.CrossRefPubMed
53.
Magidson JF, Blashill AJ, Safren SA, Wagner GJ. Depressive symptoms, lifestyle structure, and ART adherence among HIV-infected individuals: a longitudinal mediation analysis. AIDS Behav. 2015;19(1):34–40.CrossRefPubMedPubMedCentral
54.
Sharpe TT, Lee LM, Nakashima AK, Elam-Evans LD, Fleming PL. Crack cocaine use and adherence to antiretroviral treatment among HIV-infected Black women. J Community Health. 2004;29(2):117–27.CrossRefPubMed
55.
Baum MK, Rafie C, Lai S, Sales S, Page B, Campa A. Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users. J Acquir Immune Defic Syndr. 2009;50(1):93–9.CrossRefPubMed
56.
Duncan R, Shapshak P, Page JB, Chiappelli F, McCoy CB, Messiah SE. Crack cocaine: effect modifier of RNA viral load and CD4 count in HIV-infected African American women. Front Biosci. 2007;12:1488–95.CrossRefPubMed
57.
Carrico AW, Johnson MO, Morin SF, Remien RH, Riley ED, Hecht FM, et al. Stimulant use is associated with immune activation and depleted tryptophan among HIV-positive persons on anti-retroviral therapy. Brain Behav Immun. 2008;22(8):1257–62.CrossRefPubMedPubMedCentral
58.
Marquez C, Mitchell SJ, Hare CB, John M, Klausner JD. Methamphetamine use, sexual activity, patient–provider communication, and medication adherence among HIV-infected patients in care, San Francisco 2004–2006. AIDS Care. 2009;21(5):575–82.CrossRefPubMed
59.
Reback C, Larkins S, Shoptaw S. Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men. AIDS Care. 2003;15(6):775–85.CrossRefPubMed
60.
Gonzalez A, Barinas J, O’Cleirigh C. Substance use: impact on adherence and HIV medical treatment. Curr HIV/AIDS Rep. 2011;8(4):223.CrossRefPubMed
61.
Iguchi MY, Bell J, Ramchand R, Fain T. How criminal system racial disparities may translate into health disparities. J Health Care Poor Underserved. 2005;16:48–56.CrossRefPubMed
62.
Minior T, Galea S, Stuber J, Ahern J, Ompad D. Racial differences in discrimination experiences and responses among minority substance users. Ethn Dis. 2003;13(4):521–7.PubMed
63.
Ramchand R, Pacula RL, Iguchi MY. Racial differences in marijuana-users’ risk of arrest in the United States. Drug Alcohol Dep. 2006;84(3):264–72.CrossRef
64.
McCabe SE, Bostwick WB, Hughes TL, West BT, Boyd CJ. The relationship between discrimination and substance use disorders among lesbian, gay, and bisexual adults in the United States. Am J Public Health. 2010;100(10):1946–52.CrossRefPubMedPubMedCentral
65.
Amola O, Grimmett MA. Sexual identity, mental health, HIV risk behaviors, and internalized homophobia among Black men who have sex with men. J Couns Dev. 2015;93(2):236–46.CrossRef
66.
Quinn K, Dickson-Gomez J. Homonegativity, religiosity, and the intersecting identities of young Black men who have sex with men. AIDS Behav. 2016;20(1):51–64.CrossRefPubMedPubMedCentral
67.
Quinn K, Dickson-Gomez J, DiFranceisco W, Kelly JA, Lawrence JS. Correlates of internalized homonegativity among Black men who have sex with men. AIDS Educ Prev. 2015;27(3):212.CrossRefPubMedPubMedCentral
68.
Lazo M, Gange SJ, Wilson TE, Anastos K, Ostrow DG, Witt MD, et al. Patterns and predictors of changes in adherence to highly active antiretroviral therapy: longitudinal study of men and women. Clin Infect Dis. 2007;45(10):1377–85.CrossRefPubMed
69.
Levine AJ, Hinkin CH, Castellon SA, Mason KI, Lam MN, Perkins A, et al. Variations in patterns of highly active antiretroviral therapy (HAART) adherence. AIDS Behav. 2005;9(3):355–62.CrossRefPubMed
70.
Kleeberger CA, Buechner J, Palella F, Detels R, Riddler S, Godfrey R, et al. Changes in adherence to highly active antiretroviral therapy medications in the Multicenter AIDS Cohort Study. AIDS. 2004;18(4):683–8.CrossRefPubMed
71.
Mannheimer S, Friedland G, Matts J, Child C, Chesney M. Terry Beirn Community Programs for Clinical Research on AIDS. The consistency of adherence to antiretroviral therapy predicts biologic outcomes for Human Immunodeficiency Virus—infected persons in clinical trials. Clin Infect Dis. 2002;34(8):1115–21.CrossRefPubMed
72.
Carrieri P, Cailleton V, Le VM, Spire B, Dellamonica P, Bouvet E, et al. The dynamic of adherence to highly active antiretroviral therapy: results from the French National APROCO cohort. J Acquir Immune Defic Syndr. 2001;28(3):232–9.CrossRefPubMed
73.
Glass TR, Battegay M, Cavassini M, De Geest S, Furrer H, Vernazza PL, et al. Longitudinal analysis of patterns and predictors of changes in self-reported adherence to antiretroviral therapy: swiss HIV Cohort Study. J Acquir Immune Defic Syndr. 2010;54(2):197–203.PubMed
74.
Voisin DR, Quinn K, Kim DH, Schneider J. A longitudinal analysis of antiretroviral adherence among young Black men who have sex with men. J Adolesc Health. 2017;60(4):411–6.CrossRefPubMed
75.
Hoover MA, Green HD, Bogart LM, Wagner GJ, Mutchler MG, Galvan FH, et al. Do people know I’m poz?: factors associated with knowledge of serostatus among HIV-positive African Americans’ social network members. AIDS Behav. 2016;20(1):137–46.CrossRefPubMedPubMedCentral
76.
Bogart LM, Mutchler MG, McDavitt B, Klein DJ, Cunningham WE, Goggin KJ, et al. A randomized controlled trial of Rise, a community-based culturally congruent adherence intervention for Black Americans living with HIV. Ann Behav Med. 2017;6(51):868–78.CrossRef
77.
Chesney MA, Ickovics J, Chambers D, Gifford A, Neidig J, Zwickl B, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. AIDS Care. 2000;12(3):255–66.CrossRefPubMed
78.
Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. Psychiatr Ann. 2002;32(9):509–15.CrossRef
79.
McLellan AT, Luborsky L, Cacciola J, Griffith J, Evans F, Barr HL, et al. New data from the Addiction Severity Index: reliability and validity in three centers. J Nerv Ment Dis. 1985;173:423.CrossRef
80.
LaVeist TA, Isaac LA, Williams KP. Mistrust of health care organizations is associated with underutilization of health services. Health Serv Res. 2009;44(6):2093–105.CrossRefPubMedPubMedCentral
81.
Lee Hargraves J, Hays RD, Cleary PD. Psychometric properties of the Consumer Assessment of Health Plans Study (CAHPS®) 2.0 adult core survey. Health Serv Res. 2003;38:1509–28.CrossRefPubMedPubMedCentral
82.
Kalichman SC, Simbayi L. Traditional beliefs about the cause of AIDS and AIDS-related stigma in South Africa. AIDS Care. 2004;16(5):572–80.CrossRefPubMed
83.
Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med. 1991;32(6):705–14.CrossRef
84.
Bangsberg DR, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, Sheiner L, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14(4):357–66.CrossRefPubMed
85.
Jones BL, Nagin DS, Roeder K. A SAS procedure based on mixture models for estimating developmental trajectories. Sociol Methods Res. 2001;29(3):374–93.CrossRef
86.
Jones BL, Nagin DS. Advances in group-based trajectory modeling and an SAS procedure for estimating them. Sociol Methods Res. 2007;35(4):542–71.CrossRef
87.
Booth GD, Niccolucci MJ, Schuster EG. Identifying proxy sets in multiple linear regression: an aid to better coefficient interpretation. Research paper INT. 1994.
88.
Dormann CF, Elith J, Bacher S, Buchmann C, Carl G, Carré G, et al. Collinearity: a review of methods to deal with it and a simulation study evaluating their performance. Ecography. 2013;36(1):27–46.CrossRef
89.
Wilson IB, Bangsberg DR, Shen J, et al., editors. Heterogeneity among studies in rates of declines of antiretroviral therapy (ART) adherence over time: findings from MACH14 (# 62221). In: 5th international conference on HIV treatment adherence, Miami, FL; 2010.
90.
Carrico AW, Johnson MO, Colfax GN, Moskowitz JT. Affective correlates of stimulant use and adherence to anti-retroviral therapy among HIV-positive methamphetamine users. AIDS Behav. 2010;14(4):769–77.CrossRefPubMed
91.
Malta M, Strathdee SA, Magnanini MM, Bastos FI. Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review. Addiction. 2008;103(8):1242–57.CrossRefPubMed
92.
McElhiney MC, Rabkin JG, Rabkin R, Nunes EV. Provigil (modafinil) plus cognitive behavioral therapy for methamphetamine use in HIV+ gay men: a pilot study. Am J Drug Alcohol Abuse. 2009;35(1):34–7.CrossRefPubMedPubMedCentral
93.
Carrico AW, Johnson MO, Moskowitz JT, Neilands TB, Morin SF, Charlebois ED, et al. Affect regulation, stimulant use, and viral load among HIV-positive persons on anti-retroviral therapy. Psychosom Med. 2007;69(8):785–92.CrossRefPubMed
94.
Maulsby C, Millett G, Lindsey K, Kelley R, Johnson K, Montoya D, et al. HIV among Black men who have sex with men (MSM) in the United States: a review of the literature. AIDS Behav. 2014;18(1):10–25.CrossRefPubMed
95.
Bakken S, Holzemer WL, Brown M-A, Powell-Cope GM, Turner JG, Inouye J, et al. Relationships between perception of engagement with health care provider and demographic characteristics, health status, and adherence to therapeutic regimen in persons with HIV/AIDS. AIDS Patient Care STDs. 2000;14(4):189–97.CrossRefPubMed
96.
Beach MC, Keruly J, Moore RD. Is the quality of the patient-provider relationship associated with better adherence and health outcomes for patients with HIV? J Gen Intern Med. 2006;21(6):661–5.CrossRefPubMedPubMedCentral
97.
Ingersoll KS, Heckman CJ. Patient–clinician relationships and treatment system effects on HIV medication adherence. AIDS Behav. 2005;9(1):89–101.CrossRefPubMedPubMedCentral
98.
Mathes T, Pieper D, Antoine SL, Eikermann M. Adherence-enhancing interventions for highly active antiretroviral therapy in HIV-infected patients: a systematic review. HIV Med. 2013;14(10):583–95.CrossRefPubMed
99.
Simoni JM, Amico KR, Smith L, Nelson K. Antiretroviral adherence interventions: translating research findings to the real world clinic. Curr HIV/AIDS Rep. 2010;7(1):44–51.CrossRefPubMedPubMedCentral
100.
Amico KR, Harman JJ, Johnson BT. Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996 to 2004. J Acquir Immune Defic Syndr. 2006;41(3):285–97.CrossRefPubMed
Metadaten
Titel
Antiretroviral Adherence Trajectories Among Black Americans Living with HIV
verfasst von
Erik D. Storholm
Laura M. Bogart
Matt G. Mutchler
David J. Klein
Bonnie Ghosh-Dastidar
Bryce McDavitt
Glenn J. Wagner
Publikationsdatum
17.10.2018
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 8/2019
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-018-2303-2

Weitere Artikel der Ausgabe 8/2019

AIDS and Behavior 8/2019 Zur Ausgabe

Original Paper

Demand and Supply Motivations for Antiretroviral Drugs in Illicit Street Markets: The Case of Atlanta, Georgia

Original Paper

Accuracy of HIV Risk Perception in East Zimbabwe 2003–2013

Substantive Review

A Systematic Review and Meta-analysis of Antiretroviral Therapy (ART) Adherence Interventions for Women Living with HIV

Original Paper

ART Denial: Results of a Home-Based Study to Validate Self-reported Antiretroviral Use in Rural South Africa

Original Paper

Testing the Feasibility of Using Ecological Momentary Assessment to Collect Real-Time Behavior and Mood to Predict Technology-Measured HIV Medication Adherence

Original Paper

Determinants, Prevalence and Trend of Use of Medicinal Plants Among People Living with HIV: A Cross-Sectional Survey in Dschang, Cameroon

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise